X-47142394-G-A
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PVS1_StrongPM2PP5_Very_Strong
The NM_001135998.3(NDUFB11):c.385C>T(p.Arg129*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_001135998.3 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 22
ClinVar
Submissions by phenotype
Linear skin defects with multiple congenital anomalies 3 Pathogenic:1
This nonsense variant found in exon 3 of 3 is predicted to alter the protein product but is not expected to trigger nonsense-mediated mRNA decay. This variant has not been previously reported or functionally characterized in the literature to our knowledge. It is absent from the gnomAD population database and thus presumed to be rare. Analysis of the parental samples was negative for the variant, indicating this variant likely occurred as a de novo event. Based on the available evidence, the c.415C>T (p.Arg139Ter) variant is classified as Likely Pathogenic. -
NDUFB11-related disorders Pathogenic:1
The NDUFB11 c.415C>T variant is predicted to result in premature protein termination (p.Arg139*). This variant is located in the last exon of NDUFB11; therefore, it is unknown if the resulting mRNA would result in nonsense-mediated decay. However, at least one other protein-truncating variant was described on the last exon in an individual who presented with NDUFB11-related disease (van Rahden et al. 2015. PubMed ID: 25772934). To our knowledge, this variant has not been reported in the literature or in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. At PreventionGenetics, we previously detected this variant as de novo in an individual who presented with histiocytoid cardiomyopathy. Note that variable clinical features have been described in patients with NDUFB11-related disease (see, for example, Rea et al. 2017. PubMed ID: 28050600; Amate-Garcia et al. 2023. PubMed ID: 36675256). Taken together, we classify this variant as likely pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.